PDL BioPharma Completes Regular Quarterly Dividend Payment
INCLINE VILLAGE, Nev., March 14, 2012 /PRNewswire/ --PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the March 14, 2012, regular quarterly dividend payment of $0.15 per share to all stockholders owning shares of PDL as of March 7, 2012, the record date.
(Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)
About PDL BioPharma
PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new royalty bearing assets and maximizing the value of its patent portfolio and related assets. For more information, please visit www.pdl.com.
NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.
SOURCE PDL BioPharma, Inc.
RELATED LINKS
http://www.pdl.com
More by this Source
PDL BioPharma Announces First Quarter 2013 Financial Results
May 09, 2013, 16:02 ET
PDL BioPharma to Announce First Quarter 2013 Financial Results on May 9, 2013
May 02, 2013, 07:00 ET
PDL BioPharma Appoints Peter Garcia as Chief Financial Officer
Apr 30, 2013, 16:02 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.
- Site Preview
-
Close Site Preview
-
View FullScreen
